Mary-Lacey Reuther is the Head of North America Policy, Advocacy and Government Affairs (PAGA) for CSL Behring. Mary-Lacey is responsible for leading the team that develops and implements the North America strategic public policy advocacy priorities to support the CSL Behring commercialized therapeutic areas, pipeline therapies and plasma operations. This entails public policy impact analysis, direct interactions with governmental entities and third-party stakeholder engagement.
Mary-Lacey has worked in health care policy for over 25 years. Her previous roles include establishing the government affairs function for Acadia Pharmaceuticals and leading the federal affairs function at Astellas Pharmaceuticals. Prior to this she was a Vice President at a leading Washington, DC lobbying firm, and she worked at several life science trade associations. Mary-Lacey is most proud of her U.S. government service where she served as the Special Assistant to Dr. Mark McClellan during his tenures as both the Food and Drug Administration (FDA) Commissioner and Centers for Medicare and Medicaid Services (CMS) Administrator.
Mary-Lacey earned a Bachelor of Science in Communications from the University of Tennessee in Knoxville, TN. She lives in the Washington, DC area with her husband, Bill, and their three children.
